Roche has obtained U.S. government green lights allowing its point-of-care testing system to be used to screen for multiple sexually transmitted infections from a single sample. | The company’s cobas ...
SCHD said that the partnership will allow expanded clinical services, enabling the health department to provide HIF and ...
A new strain of gonorrhea has emerged, causing significant concern among health professionals due to its resistance to traditional treatments. This sexually ...
The agreement would allow SCHD to connect students with clinicians to expand access to screenings and care for middle and high school students.
GlobalData on MSN16h
Roche’s STI assay panels gain FDA 510(k) clearance and CLIA waiverLeveraging gold-standard PCR technology, the cobas liat system claims to deliver outcomes in under 20 minutes.
KOCHI: The fourth leading cause of cancer among women globally and the second that affects Indian women is cervical cancer.
The Star on MSN9h
EXPLAINER: What you need to know about HPV vaccineAccording to the Centers for Disease Control and Prevention, the HPV vaccine has different side effects. These include pain, redness, or swelling in the arm where the shot was given.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback